{"id":"paper-or-2026-086574","type":"book","url":"https://diginpl.com/books/paper-or-2026-086574","language":"en","name":"PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma","name_en":"PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma","name_ne":null,"description":"Oncology Research · I-Chang Shih, Chung-Yung Ma, Horng-Dar Wang et al. · 2026","headline":"Oncology Research · I-Chang Shih, Chung-Yung Ma, Horng-Dar Wang et al. · 2026","also_known_as":[],"summary":"","summary_more":[],"facts":[{"key":"authors","label":"Author","values":[{"text":"I-Chang Shih"},{"text":"Chung-Yung Ma"},{"text":"Horng-Dar Wang"},{"text":"Chiou-Hwa Yuh"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.086574"}},{"key":"published","label":"Published","values":[{"text":"2026","date":"2026"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.086574"}},{"key":"publisher","label":"Publisher","values":[{"text":"Tech Science Press"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.086574"}},{"key":"journal","label":"Journal","values":[{"text":"Oncology Research"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.086574"}},{"key":"doi","label":"DOI","values":[{"text":"10.32604/or.2026.086574","url":"https://doi.org/10.32604/or.2026.086574"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/or.2026.086574"}}],"office":null,"sections":[],"cited":[],"cited_from":null,"videos":[],"last_reviewed":null,"organizations":[],"same_as":["https://doi.org/10.32604/or.2026.086574"],"faq":[{"q":"Who wrote PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma?","a":"PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma was written by I-Chang Shih, Chung-Yung Ma, Horng-Dar Wang, Chiou-Hwa Yuh."},{"q":"When was PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma first published?","a":"PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma was first published in 2026."}],"related":[],"places_in":[],"nearby":[],"image":null,"sources":[{"label":"Publisher record (DOI, via Crossref)","url":"https://doi.org/10.32604/or.2026.086574","license":null}],"license":null,"attribution":"Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.086574.","cite":"\"PRS-OPT–Guided Optimization Identifies a Metabolically Selective Combination of N-Acetylcysteine, Valproic Acid, and Indomethacin for Hepatocellular Carcinoma\". DigiNepal. Last updated 9 October 2026. https://diginpl.com/books/paper-or-2026-086574. Retrieved 10 November 2026.","date_modified":"2026-10-09T06:16:29Z","facts_checked":"2026-11-09","alternates":{"html":"https://diginpl.com/books/paper-or-2026-086574","en":"https://diginpl.com/books/paper-or-2026-086574","ne":null}}